JPH0372060B2 - - Google Patents
Info
- Publication number
- JPH0372060B2 JPH0372060B2 JP18659783A JP18659783A JPH0372060B2 JP H0372060 B2 JPH0372060 B2 JP H0372060B2 JP 18659783 A JP18659783 A JP 18659783A JP 18659783 A JP18659783 A JP 18659783A JP H0372060 B2 JPH0372060 B2 JP H0372060B2
- Authority
- JP
- Japan
- Prior art keywords
- imidazole
- aqueous solution
- crystals
- anion exchange
- exchange resin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 99
- 239000007864 aqueous solution Substances 0.000 claims description 30
- 239000013078 crystal Substances 0.000 claims description 22
- 239000003957 anion exchange resin Substances 0.000 claims description 16
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 14
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 13
- 238000002425 crystallisation Methods 0.000 claims description 10
- 230000008025 crystallization Effects 0.000 claims description 10
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 8
- 239000012452 mother liquor Substances 0.000 claims description 8
- 229940015043 glyoxal Drugs 0.000 claims description 7
- 229910021529 ammonia Inorganic materials 0.000 claims description 4
- 238000001953 recrystallisation Methods 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000004821 distillation Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000012535 impurity Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000012736 aqueous medium Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 description 2
- 238000005292 vacuum distillation Methods 0.000 description 2
- 241001550224 Apha Species 0.000 description 1
- 229920001890 Novodur Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000011437 continuous method Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012609 strong anion exchange resin Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
Description
【発明の詳細な説明】
本発明は不純物の少ないイミダゾ−ルを得るこ
とを目的とするものである。
イミダゾ−ルは殺菌剤、その他の農薬.医薬等
の原料として有用なものである。該化合物がグリ
オキザ−ル、ホルマリン、アンモニアを反応させ
ることにより得られることは従来より広く知られ
ており、工業的規模での実施に当つては、前記の
反応終了後に得られたイミダゾ−ル含有水性溶液
を濃縮し、次いで減圧.蒸留に付して留去するイ
ミダゾ−ルを凝縮.結晶化させる方法が行われ
る。更に通常は上記結晶を適量の水に溶解させ
て、再結晶を行い、目的とする製品を得ている。
しかしながら本発明者等が検討したところ、蒸
留、再結晶等の操作を行つても製品中には尚、微
量の不純物が混入するため、製品の放置安定性に
問題が起り、例えば夏場等の高温下で長期にわた
つて保存したり、輸送すると経時変化を起し着色
する事があり、製品価値を損う欠点があるが判明
した。
しかるに本発明者らは、上記問題を解決するた
め鋭意研究を重ねた結果、グリオキザ−ル、ホル
マリン、アンモニアを反応させて得られるイミダ
ゾ−ル含有水性溶液からイミダゾ−ルの結晶を得
るに当り、該イミダゾ−ル含有水性溶液をアニオ
ン交換樹脂で処理した後、晶析を行う場合、不純
物が少なく又経時変化の少ないイミダゾ−ルの結
晶が得られることを発見し、本発明を完成させる
に到つた。
以下本発明を順に説明する。
本発明においていうところのアニオン交換樹脂
とは交換基として第四アンモニウム塩基型、第
一、第二、第三アミンを有するスチレン系樹脂、
各種アミン縮合系樹脂など市販の交換樹脂が任意
に使用できる。かかるアニオン交換樹脂の市販商
品名の主なものを列挙するとAmberlite(Rohm
& HassCo製)、ダイヤイオン(三菱化成工業
(株)製)、Dowex(Dow Chemical Co製)、Duolite
(Chemical Process製)、Lewatit(Bayer製)等
が挙げられる。又、かかる樹脂の中でも一般に強
アニオン交換樹脂、即ち交換基として第四アンモ
ニウム塩基型を有するものが好ましく使用され
る。
本発明の精製の対象となるイミダゾ−ル含有水
性溶液は従来公知の方法によつて反応・製造され
るものである。即ち、アンモニア水溶液に温度70
〜85℃より好ましくは70〜80℃に保ちながら、グ
リオキザ−ル水溶液とホルマリン水溶液の混合液
を少量ずつ滴下して反応を行う。各々の最適反応
モル比(固形分換算)はグリオキザ−ル1モルに
対し、ホルマリンを0.7〜1.2モル、アンモニアを
2.0〜3.0である。一般に各々の原料は水溶液とし
て市販されているので、それを直接使用するのが
普通であるが、必要に応じて希釈あるいは濃縮を
行つてもよい。原料の好適な濃度範囲はグリオキ
ザ−ル水溶液が10〜80重量%、より好ましくは35
〜50重量%、ホルマリン水溶液が10〜80重量%、
より好ましくは30〜40重量%、アンモニア水溶液
が5〜40重量%、より好ましくは10〜30重量%の
ものである。反応終了後、0.5〜1時間熟成させ
てイミダゾ−ル含有の反応液を得る。
かくして得られるイミダゾ−ル含有水性溶液に
はイミダゾ−ルの他に未反応の原料、水、その他
副生物が同時に存在する。本発明においてはかか
るイミダゾ−ル含有水性溶液をそのままあるいは
適宜濃度を調整した後アニオン交換樹脂で処理
し、得られる処理液を冷却することによつて晶析
をすれば経時変化の少ないイミダゾ−ルが得られ
るのである。しかし実用的には更に高品質の製品
を得るために、上記の反応終了液をまず濃縮後、
蒸留してアニオン交換樹脂で処理するのが有効で
ある。蒸留自体は特別な操作は何等必要でない
が、特に本出願人が先に出願したところの方法に
より、濃縮・蒸留を行う(特願昭58−133212号)
場合、非常に好ましい結果が得られる。蒸留にお
ける最も代表的な方法としてはイミダゾ−ル含有
水性濃縮液を20torr以下、より好ましくは10torr
以下の減圧下190〜210℃で真空蒸留を行う方法が
採用される。
蒸留によつて留出、取得されるイミダゾ−ルは
凝縮・結晶化されるのでアニオン交換樹脂によつ
て処理するためには、該結晶を水性媒体に溶解す
ることが必要である。かかる水性溶液をアニオン
交換樹脂で処理するに当つては、特にその方法に
制限はなく、イミダゾ−ル含有水性溶液とアニオ
ン交換樹脂とを混合するバツチ方式、あるいは
塔、充填管等にアニオン交換樹脂を充填し、上部
よりイミダゾ−ル含有水性溶液を通過させる連続
方式等、任意の方法が実施できるが工業的には後
者が実用的である。更に水性溶液をアニオン交換
樹脂膜によつて処理することも勿論可能である。
処理液の濃度は60〜75重量%程度が適当である。
かくして得た処理後のイミダゾ−ル含有水性溶液
からイミダゾ−ル結晶を得る。該液は必要ならば
濃縮等によつてイミダゾ−ル濃度を75〜80重量%
程度に調製した後、温度10〜25℃、好ましくは15
〜20℃に冷却することによつて晶析させる。析出
した結晶は遠心分離、吸引過等の適当な方法を
用いて母液と分離し、適宜冷水によつて水洗を施
した後、温度75〜80℃で乾燥する。
この際得られる母液中にはかなりのイミダゾ−
ルが含有されているのでこれを処理対象のイミダ
ゾ−ル含有水性溶液と混合するか又は前記蒸留に
よつて凝縮・結晶化されたイミダゾ−ルを該母液
に溶解する等水性媒体として再使用することが有
利である。即ち、前述した晶析の際に用いる水性
媒体としての水の一部に母液を使用するのであ
る。通常、回収母液を再使用する場合、その回数
が多くなると結晶中に含まれる不純物が多くな
り、経時変化を起し易くなるほどの傾向が更に強
くなり、製品としては好ましくないものが得られ
るよになるのであるが、本発明ではアニオン交換
樹脂処理を行うのでかかる心配は全くない点が大
きな特色である。
一般に一度使用したアニオン交換樹脂は、通常
50〜10重量%程度の濃度のアルカリ水溶液で再生
し、更に適量の水で洗つた後、次のイミダゾ−ル
含有水性溶液の処理に供される。アルカリ水溶液
としては水酸化ナトリウム水溶液、水酸化カリウ
ム水溶液が用いられる。
かくして得られるイミダゾ−ルの精製結晶は常
に高純度であり、例えば光に曝されても経時変化
はほとんど起らず、その工業的な価値は非常に高
いものである。
以下実施例をあげて本発明を更に詳しく説明す
る。但し例中「%」とあるのは特にことわりのな
い限り重量基準である。
実施例
80℃に保つた20%アンモニア水溶液に攪拌下、
40%グリオキザ−ル水溶液5モルと37%ホルマリ
ン水溶液5モルの混合液を2時間かけて滴下し、
滴下終了後更に30分間熟成して反応を行つた。
該液を130℃、常圧で濃縮を行い更に210℃、
5torrで真空蒸留を行つてイミダゾ−ルの結晶を
得た。
該結晶375gに水125gを加え、30℃でイミダゾ
−ルを加温溶解し、ダイヤイオンSA−20A(SV
=2.0〜3.0、三菱化成工業(株)製アニオン交換樹脂
商品名)75mlをつめたカラム(サイズ:100〜150
ml)に通液し、通液後更に水220gをカラムに流
した。
得られた液約720gを100torr、100℃にて濃縮
して、冷却後15〜18℃で晶析を行つた。得られた
結晶は遠心分離で分離して75℃で2時間乾燥し
た。該結晶をAする。
一方、遠心分離により得られた母液343.5gに
別途前記蒸留後のイミダゾ−ル結晶140gとイミ
ダ−ル飽和液16.5gを加えて温度30℃で前記と同
じ様に均一溶解した。該液に予め5%アルカリ水
溶液200ml、更に水500mlを流して再生したアニオ
ン交換樹脂に通液して、以下同様にして晶析し、
結晶を得た。該結晶をBとする。
以下、順次逐次得られた母液を再使用して前述
した操作を繰り返し、晶析を計3回行つて、イミ
ダゾ−ルの結晶を得た。これらの結晶を晶析順に
C、D、Eとする。 A〜Eの精製結晶の融点、
純度及び結晶のAPHAを測定した。
結果を第1表に示す。
対照例
実施例においてアニオン交換樹脂の代わりに活
性炭(粒状、SV=2.5)を用いた以外は同例と同
様にして母液をリサイクルし晶析を計5回行つ
た。これらの結晶を晶析順にA′、B′、C′、D′、
E′とする。
各結晶について実施例同様の分析・測定を行つ
た。
結果を第1表に併せて示す。
【表】DETAILED DESCRIPTION OF THE INVENTION The object of the present invention is to obtain imidazole with few impurities. Imidazole is a fungicide and other agricultural chemicals. It is useful as a raw material for medicines, etc. It has been widely known that this compound can be obtained by reacting glyoxal, formalin, and ammonia, and when carried out on an industrial scale, it is necessary to use the imidazole-containing compound obtained after the completion of the reaction. The aqueous solution was concentrated and then reduced under reduced pressure. The imidazole that is distilled off is condensed. A method of crystallization is performed. Furthermore, the desired product is usually obtained by dissolving the crystals in an appropriate amount of water and recrystallizing them. However, the present inventors have investigated that even if operations such as distillation and recrystallization are carried out, trace amounts of impurities are still mixed into the product, causing problems with the product's storage stability. It has been discovered that if it is stored for a long time or transported for a long time, it may change over time and become discolored, which reduces the value of the product. However, as a result of extensive research in order to solve the above problem, the present inventors found that in obtaining imidazole crystals from an imidazole-containing aqueous solution obtained by reacting glyoxal, formalin, and ammonia, The inventors have discovered that when the imidazole-containing aqueous solution is treated with an anion exchange resin and then subjected to crystallization, imidazole crystals with few impurities and little change over time can be obtained, which led them to complete the present invention. Ivy. The present invention will be explained in order below. In the present invention, the anion exchange resin is a styrenic resin having a quaternary ammonium base type, primary, secondary, or tertiary amine as an exchange group;
Commercially available exchange resins such as various amine condensation resins can be used arbitrarily. The main commercial product names of such anion exchange resins are Amberlite (Rohm
& HassCo), Diaion (Mitsubishi Chemical
Co., Ltd.), Dowex (manufactured by Dow Chemical Co.), Duolite
(manufactured by Chemical Process), Lewatit (manufactured by Bayer), etc. Among such resins, strong anion exchange resins, ie, those having a quaternary ammonium base type as an exchange group, are generally preferably used. The imidazole-containing aqueous solution to be purified in the present invention is reacted and produced by a conventionally known method. That is, the ammonia aqueous solution has a temperature of 70°C.
The reaction is carried out by dropping a mixture of glyoxal aqueous solution and formalin aqueous solution little by little while maintaining the temperature at -85°C, preferably 70-80°C. The optimum reaction molar ratio (in terms of solid content) is 0.7 to 1.2 mol of formalin and 0.7 to 1.2 mol of ammonia to 1 mol of glyoxal.
It is between 2.0 and 3.0. Since each raw material is generally commercially available as an aqueous solution, it is common to use it directly, but it may be diluted or concentrated as necessary. The preferred concentration range of the raw material is glyoxal aqueous solution of 10 to 80% by weight, more preferably 35% by weight.
~50% by weight, formalin aqueous solution 10-80% by weight,
More preferably 30 to 40% by weight, 5 to 40% by weight of ammonia aqueous solution, and more preferably 10 to 30% by weight. After the reaction is completed, the mixture is aged for 0.5 to 1 hour to obtain an imidazole-containing reaction solution. The imidazole-containing aqueous solution thus obtained contains imidazole as well as unreacted raw materials, water, and other by-products. In the present invention, such an imidazole-containing aqueous solution is treated with an anion exchange resin as it is or after adjusting the concentration appropriately, and the resulting treated solution is cooled to crystallize, thereby producing an imidazole with little change over time. is obtained. However, in practical terms, in order to obtain a product of even higher quality, the above-mentioned reaction-completed liquid is first concentrated, and then
It is effective to distill it and treat it with an anion exchange resin. Distillation itself does not require any special operations, but concentration and distillation are carried out by the method previously applied by the present applicant (Japanese Patent Application No. 133212/1982).
In this case, very favorable results are obtained. The most typical method for distillation is to distill an imidazole-containing aqueous concentrate under 20 torr, more preferably at 10 torr.
The following method of vacuum distillation at 190 to 210°C under reduced pressure is adopted. Since the imidazole obtained by distillation is condensed and crystallized, it is necessary to dissolve the crystals in an aqueous medium for treatment with an anion exchange resin. When treating such an aqueous solution with an anion exchange resin, there are no particular restrictions on the method, and the method may be a batch method in which an aqueous imidazole-containing solution and an anion exchange resin are mixed, or an anion exchange resin is added to a column, a packed tube, etc. Any method can be used, such as a continuous method in which the imidazole-containing aqueous solution is passed from the top, but the latter method is industrially practical. Furthermore, it is of course possible to treat the aqueous solution with an anion exchange resin membrane.
The appropriate concentration of the treatment liquid is about 60 to 75% by weight.
Imidazole crystals are obtained from the imidazole-containing aqueous solution thus obtained. If necessary, concentrate the solution to bring the imidazole concentration to 75-80% by weight.
After preparing to a degree, the temperature is 10-25℃, preferably 15
Crystallize by cooling to ~20°C. The precipitated crystals are separated from the mother liquor using an appropriate method such as centrifugation or suction, washed with cold water as appropriate, and then dried at a temperature of 75 to 80°C. The mother liquor obtained at this time contains a considerable amount of imidazo.
This can be reused as an aqueous medium by mixing it with the imidazole-containing aqueous solution to be treated, or by dissolving the imidazole condensed and crystallized by the distillation into the mother liquor. That is advantageous. That is, the mother liquor is used as part of the water used as the aqueous medium during the crystallization described above. Normally, when the recovered mother liquor is reused, the more times it is reused, the more impurities will be included in the crystals, and the tendency to change over time will become even stronger, resulting in an undesirable product. However, the present invention is characterized by the fact that there is no such concern since the anion exchange resin treatment is performed. Anion exchange resins that have been used once are usually
After being regenerated with an alkaline aqueous solution having a concentration of about 50 to 10% by weight and further washed with an appropriate amount of water, it is subjected to the next treatment with an imidazole-containing aqueous solution. As the alkaline aqueous solution, a sodium hydroxide aqueous solution and a potassium hydroxide aqueous solution are used. The purified imidazole crystals obtained in this way are always of high purity, and show almost no change over time even when exposed to light, and are therefore of very high industrial value. The present invention will be explained in more detail with reference to Examples below. However, "%" in the examples is based on weight unless otherwise specified. Example: Into a 20% ammonia aqueous solution kept at 80℃,
A mixture of 5 moles of 40% glyoxal aqueous solution and 5 moles of 37% formalin aqueous solution was added dropwise over 2 hours.
After completion of the dropwise addition, the mixture was further aged for 30 minutes to carry out the reaction. The liquid was concentrated at 130°C and normal pressure, and then further concentrated at 210°C.
Imidazole crystals were obtained by vacuum distillation at 5 torr. Add 125 g of water to 375 g of the crystals, dissolve the imidazole by heating at 30°C, and add Diaion SA-20A (SV
= 2.0 to 3.0, a column filled with 75 ml of anion exchange resin manufactured by Mitsubishi Chemical Industries, Ltd. (size: 100 to 150)
ml), and after passing, 220 g of water was further passed through the column. Approximately 720 g of the obtained liquid was concentrated at 100 torr and 100°C, and after cooling, crystallization was performed at 15 to 18°C. The obtained crystals were separated by centrifugation and dried at 75°C for 2 hours. The crystal is A. Separately, 140 g of the imidazole crystals after the distillation and 16.5 g of the imidal saturated solution were added to 343.5 g of the mother liquor obtained by centrifugation and uniformly dissolved at a temperature of 30 DEG C. in the same manner as above. 200 ml of a 5% alkaline aqueous solution and 500 ml of water were poured into the solution in advance, and the solution was passed through the regenerated anion exchange resin, followed by crystallization in the same manner.
Obtained crystals. This crystal is designated as B. Thereafter, the above-described operations were repeated by successively reusing the obtained mother liquors, and crystallization was performed three times in total to obtain imidazole crystals. These crystals are designated as C, D, and E in the order of crystallization. Melting points of purified crystals of A to E,
The purity and APHA of the crystals were determined. The results are shown in Table 1. Control Example The mother liquor was recycled and crystallization was performed 5 times in the same manner as in Example except that activated carbon (granular, SV=2.5) was used instead of the anion exchange resin. The order of crystallization of these crystals is A′, B′, C′, D′,
Let it be E′. Each crystal was analyzed and measured in the same manner as in the example. The results are also shown in Table 1. 【table】
Claims (1)
反応させて得られるイミダゾ−ル含有水性溶液か
らイミダゾ−ルの結晶を得るに当り、該イミダゾ
−ル含有水性溶液をアニオン交換樹脂で処理した
後、晶析を行うことを特徴とするイミダゾ−ルの
精製方法。 2 水性溶液の媒体として再結晶特に得られる母
液を再使用する特許請求の範囲第1項記載の精製
方法。[Claims] 1. In obtaining imidazole crystals from an imidazole-containing aqueous solution obtained by reacting glyoxal, formalin, and ammonia, the imidazole-containing aqueous solution is treated with an anion exchange resin. 1. A method for purifying imidazole, which comprises performing crystallization. 2. The purification method according to claim 1, wherein the recrystallization, particularly the obtained mother liquor, is reused as a medium for the aqueous solution.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18659783A JPS6078970A (en) | 1983-10-04 | 1983-10-04 | Method for purifying imidazole |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18659783A JPS6078970A (en) | 1983-10-04 | 1983-10-04 | Method for purifying imidazole |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6078970A JPS6078970A (en) | 1985-05-04 |
| JPH0372060B2 true JPH0372060B2 (en) | 1991-11-15 |
Family
ID=16191335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP18659783A Granted JPS6078970A (en) | 1983-10-04 | 1983-10-04 | Method for purifying imidazole |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6078970A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6177575B1 (en) * | 1998-06-12 | 2001-01-23 | E. I. Du Pont De Nemours And Company | Process for manufacture of imidazoles |
-
1983
- 1983-10-04 JP JP18659783A patent/JPS6078970A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6078970A (en) | 1985-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5254729A (en) | Method for purifying glycine | |
| US5258550A (en) | Process for preparing glycine | |
| JPH04334359A (en) | Production of carbodihydrazide | |
| KR950001631B1 (en) | How to prepare glycine | |
| JPH0372060B2 (en) | ||
| US5587511A (en) | Process for obtaining adipic acid | |
| JPH01211544A (en) | Production of bisphenol a | |
| US6383127B2 (en) | Method of crystallizing tetrabromobisphenol A | |
| JP2004010566A (en) | Method for producing bisphenol a | |
| US4113771A (en) | Process for the purification of citric acid | |
| JP2907582B2 (en) | Glycine purification method | |
| JPS584017B2 (en) | Guanidine Enruino Seihou | |
| JPS6338020B2 (en) | ||
| US5283046A (en) | Method for re-use of aqueous co-product from manufacture of sodium dithionite | |
| JP2954556B2 (en) | Glycine production method | |
| US6011184A (en) | Descaling of bisphenol-A reactor using water | |
| JPH03232848A (en) | Production of glycine | |
| US2780655A (en) | Recovery of pentaerythritol by formalin extraction | |
| US4066688A (en) | Chemical process | |
| US4997635A (en) | Preparation of crystalline hydroxylammonium sulfate having a low ammonium sulfate content | |
| JPH04210945A (en) | Production of glycine | |
| US5302754A (en) | Purification process of methacrylamide | |
| US3642888A (en) | Process for preparing beta-alanine | |
| JPH0372214B2 (en) | ||
| JPH03232847A (en) | Production of glycine |